[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368429-105":59,"doc-detail-368429-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","expression-and-immunological-role-of-fundc2-in-pan-cancer","Expression and immunological role of FUNDC2 in pan-cancer","","FUNDC2 is a newly described mitochondrial protein implicated in multiple cancers, yet its expression patterns and immunological functions across pan-cancer remain unclear. This study uses TIMER 2.0 to profile FUNDC2 expression and immune infiltration, GEPIA to associate FUNDC2 levels with patient prognosis, STRING to identify candidate interacting proteins, and cBioPortal/PhosphoNet to predict phosphorylation sites. AlphaFold predicts FUNDC2 structure. Results show significant differences between tumor and control tissues, lower FUNDC2 in eight cancers, longer survival with higher FUNDC2, links to B-cell immune infiltration, and predicted interactions with FUNDC1.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/expression-and-immunological-role-of-fundc2-in-pan-cancer/368429/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/expression-and-immunological-role-of-fundc2-in-pan-cancer/368429.png","ImageObject",300,407,{"name":92,"@type":93},"Jacob","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main scientific question of the study?","Question",{"text":112,"@type":113},"The study asks how FUNDC2 is expressed across pan-cancer and what immunological role and mechanism FUNDC2 may play in cancer.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which bioinformatics tools are used to analyze FUNDC2?",{"text":117,"@type":113},"TIMER 2.0 is used for expression and immune infiltration, GEPIA for prognosis, STRING for interacting proteins, cBioPortal and PhosphoNet for phosphorylation-site prediction, and AlphaFold for structure prediction.",{"name":119,"@type":110,"acceptedAnswer":120},"What do the results indicate about FUNDC2 and cancer prognosis?",{"text":121,"@type":113},"FUNDC2 expression differs significantly between cancer tissues and controls; in most cancer types, higher FUNDC2 is associated with longer survival, and FUNDC2 correlates with immune infiltration, particularly B cells.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368429,1790321314,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962084931830,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","OPEN ACCESS  \nCitation: Qiu X, Wang S, Li C, Wang Y (2025) Expression and immunological role of FUNDC2 in pan-cancer. PLoS One 20(4): e0319343 .  \n[https://doi.org/10.1371/journal.pone.0319343](https://doi.org/10.1371/journal.pone.0319343)  \nEditor: Jinhui Liu, The First Affiliated Hospital of Nanjing Medical University, CHINA Received: November 17, 2024  \nAccepted: January 30, 2025  \nPublished: April 28, 2025  \nPeer Review History: PLOS recognizes the benefits of transparency in the peer review process; therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. The editorial history of this article is available here: [https://doi.org/10.1371/journal](https://doi.org/10.1371/journal). pone.0319343  \nCopyright: © 2025 Qiu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  \nRESEARCH ARTICLE  \nExpression and immunological role of FUNDC2 in pan-cancer  \nXirong Qiu*, Shuyu Wang, Chenlu Li, Yinan Wang  \nDepartment of Pharmacology, School of Medicine, Lijiang Culture and Tourism College, Lijiang, Yunnan, China  \n* [ynkmq6688@outlook.com](ynkmq6688@outlook.com)  \nAbstract  \nFUNDC2 is a novel mitochondrial protein and is highly involved in various cancers. However, expression pattern and possible role and mechanism of FUNDC2 in  \npan-cancer remain to be investigated. TIMER 2.0 was used to investigate the expression patterns and immune infiltration of FUNDC2 . GEPIA was applied to study the relationship between level of FUNDC2 and prognosis of the patients with pan-cancer. STRING was employed to analyze the potential interacting proteins of FUNDC2 . The phosphorylation sites were predicted by cBioPortal and PhosphoNet. Furthermore, variations of FUNDC2 in cancers were investigated by cBioPortal. Finally, AlphaFold was used to predict the structure of FUNDC2 . The data show that there were significant differences in the expression levels of FUNDC2 between cancer tissues and controls. Specifically, the levels of FUNDC2 in 8 cancers were significantly lower than the respective controls. The survival time of the cancer patients with higher levels of FUNDC2 was longer than that of lower FUNDC2 in most different types of cancers. The pattern of FUNDC2 was significantly related to immune infiltration of B cells of cancer patients. STRING analysis revealed that FUNDC2 can interact with FUNDC1, et al. Fifteen phosphorylation sites were predicted by PhosphoNet and cBioPortal, of which the S167 also overlapped with the mutation sites of FUNDC2 . These data collectively show that the mitochondrial protein FUNDC2 may serve as a possible prognostic biomarker across various cancers and the mechanism may include immune infiltration.  \nIntroduction  \nFUN14 domain-containing protein 2 (FUNDC2) with 176 amino acids is a novel mitochondrial protein [ 1] . It is also involved in cell apoptosis and ferroptosis, which is highly involved in various cancers [2–5] . However, expression level and clinical significance of FUNDC2 in cancers remain to be investigated.  \nPLOS One | [https://doi.org/10.1371/journal.pone.0319343](https://doi.org/10.1371/journal.pone.0319343) April 28, 2025 1 / 14  \nData availability statement: All relevant data can be obtained from the TIMER 2.0 database ([http://cistrome.org/TIMER/](http://cistrome.org/TIMER/)), GEPIA ([http://](http://)[ ](http://)[gepia.cancer-pku.cn/](gepia.cancer-pku.cn/)), STRING database ([https://string-db.org/](https://string-db.org/)), cBioportal database ([http://www.cbioportal.org](http://www.cbioportal.org)), Phosphonet website ([http://www.phosphonet.ca/default.aspx](http://www.phosphonet.ca/default.aspx)), AlphaFold ([https://alphafold.ebi.ac.uk/](https://alphafold.ebi.ac.uk/)), Uniprot  \ndatabase ([https://www.uniprot.org/](https://www.unipro","cbCaio7fBY6Sr9GV","https://ap.wps.com/l/cbCaio7fBY6Sr9GV","pdf",2110775,14,"English","# Abstract\n# Introduction\n# Materials and methods","[{\"question\":\"What is the main scientific question of the study?\",\"answer\":\"The study asks how FUNDC2 is expressed across pan-cancer and what immunological role and mechanism FUNDC2 may play in cancer.\"},{\"question\":\"Which bioinformatics tools are used to analyze FUNDC2?\",\"answer\":\"TIMER 2.0 is used for expression and immune infiltration, GEPIA for prognosis, STRING for interacting proteins, cBioPortal and PhosphoNet for phosphorylation-site prediction, and AlphaFold for structure prediction.\"},{\"question\":\"What do the results indicate about FUNDC2 and cancer prognosis?\",\"answer\":\"FUNDC2 expression differs significantly between cancer tissues and controls; in most cancer types, higher FUNDC2 is associated with longer survival, and FUNDC2 correlates with immune infiltration, particularly B cells.\"}]","Expression and immunological role of FUNDC2 in pan-cancer | PDF",1790176916,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/54c9503831c09455c6ff7854d7061101.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3cc85c0b0a2e172f780411b24df18841.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/45e725020dd2ee700bc140a6a1213ff9.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/03e4dede284f783273d394faf20fc28b.webp",980,1268]